Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Sprout Health vs Wisp

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.5

Sprout Health

Best for LegitScript-verified compounded GLP-1 via named pharmacies
★★★3.8

Starting at $249/mo

CompoundedSemaglutideTirzepatideLegitScript Verified
Visit Sprout Health
7.0

Wisp

Best for buyers who want a board-certified telehealth platform offering both branded injectables AND a sublingual alternative — with full disclosure that the sublingual form is not human-tested
★★★3.5

Starting at $225/mo

Brand WegovyBrand ZepboundBrand SaxendaCompounded Sublingual Semaglutide
Visit Wisp

Side-by-Side Comparison

FeatureSprout HealthWisp
Overall Score7.5/107.0/10
Starting Price$249/mo$225/mo
Editorial Rating3.8 ★ /53.5 ★ /5
Features4 features6 features
States Available440
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Sprout Health

Pros

  • LegitScript certification confirmed
  • Both compounded semaglutide and tirzepatide available
  • 44-state coverage via a pre-qualification quiz and licensed clinician review
  • Two named 503A pharmacy partners: Foothills Pharmacy and Promise Pharmacy

Cons

  • Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • Not available in Alabama, Arkansas, California, Louisiana, Mississippi, or North Dakota
  • Relatively high base pricing ($249/mo for sema, $299/mo for tirz) compared to intro-priced competitors
  • Pharmacy partner accreditation details (PCAB/ACHC) not independently verified

Wisp

Pros

  • Wider GLP-1 menu than the prior stub suggested — both branded injectables (Wegovy, Zepbound, Saxenda) AND the compounded sublingual option
  • LegitScript certified, board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC publicly named)
  • Wisp's product page uses appropriately cautious language around sublingual: 'lab tests using human-derived tissues suggest it may begin working' and 'effectiveness in patients may vary' — disclosure is more rigorous than most compounded GLP-1 marketing

Cons

  • EFFECTIVENESS CAVEAT: sublingual compounded semaglutide has not been tested in humans — Wisp's own product page explicitly states this. Injectables (Wegovy, Zepbound, Saxenda) on the same platform have FDA safety/efficacy data; sublingual does not.
  • Pharmacy partners not publicly named
  • States served list not publicly enumerated

Our Verdict

Winner: Sprout HealthScore: 7.5/10

Sprout Health edges out Wisp with a higher overall score of 7.5/10 and is particularly strong for LegitScript-verified compounded GLP-1 via named pharmacies. Wisp remains a solid alternative, especially if you're looking for buyers who want a board-certified telehealth platform offering both branded injectables AND a sublingual alternative — with full disclosure that the sublingual form is not human-tested.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.